Clinicopathological Features | N | % | |
Age | ≤50 | 46 | 46.9% |
>50 | 52 | 53.1% | |
Tumor Size | <2 cm | 27 | 27.6% |
2 - 5 cm | 51 | 52.0% | |
>5 cm | 20 | 20.4% | |
Necrosis | Absent | 53 | 54.1% |
Present | 45 | 45.9% | |
Tumor Grade | Grade 1 | 20 | 20.4% |
Grade 2 | 47 | 48.0% | |
Grade 3 | 31 | 31.6% | |
LVI** | Absent | 48 | 49.0% |
Present | 50 | 51.0% | |
LNM** | Negative | 19 | 19.4% |
Positive < 3 | 48 | 49.0% | |
Positive > 3 | 31 | 31.6% | |
Tumor Stage | Stage 1 | 11 | 11.2% |
Stage 2 | 53 | 54.1% | |
Stage 3 | 24 | 24.5% | |
Stage 4 | 10 | 10.2% | |
PTEN | Negative | 53 | 54.1% |
Positive | 45 | 45.9% | |
TNBC** | TNBC | 31 | 31.6% |
Non-TNBC | 67 | 68.4% |